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Abstract  
Rhabdomyolysis and myoglobinuria are the main cause of the acute renal failure. Hyperkalemia is 
life threating complication of rhabdomyolisis due to massive cell destruction. We report a case of 
very severe hyperkalemia treated successfully with high volume hemodiafiltration (CVVHDF). 
  
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Rhabdomyolysis is a syndrome caused by 
skeletal muscle cells destruction which can occur for 
many reasons, including prolonged ischemia, 
immobilization, and trauma. The main complication of 
the syndrome is the development of acute renal 
failure. Rhabdomyolysis and myoglobinuria are 
responsible for approximately 5% of all causes of 
acute renal failure [1]. The cause of rhabdomyolysis is 
often multifactorial, and approximately 8–20% of such 
patients develop myoglobinuric acute renal failure [2]. 
Rhabdomyolysis is a process characterized 
from the destruction of the muscle cells, which leads 
to increased circulatory levels of the intracellular 
content like electrolytes, sarcoplasmatic myoglobine, 
and proteins. Acute renal failure is the main 
complication of the severe rhabdomyolysis. The 
prognosis of the acute renal failure is worse when the 
cause of the Rhabdomyolysis is trauma. We have to 
take in consideration the fact that the conventional 
dialysis does not eliminate the myoglobine, so the use 
of hemodiafiltration with super high- flux dialysis 
membrane could be an alternative of the treatment in 
these patients.  
Our aim is to present a case of acute renal 
failure with hyperkalemia, due to rhabdomyolisis, 
treated with high volumes of hemodiafiltration. 
 
Case Presentation 
A 76-year-old woman presents to our hospital 
transferred from a regional hospital with the diagnosis 
of acute lower limb ischemia (bilateral) for more than 
24 hours. The patient complains of pain in the legs, 
during rest, more prominent at the right. In the 
objective examination is noted the absence of femoral 
pulse to the right and in the popliteal artery to the left. 
Her medical history includes chronic atrial fibrillation, 
treated with beta blocker and aspirin, hypertension, 
dyslipidemia, non-insulin-dependent diabetes, and 
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mild chronic renal insufficiency (baseline creatinine 
1.4 mg/dL). 
Blood sample analysis at admission was the 
following: creatinine 1.74 mg/dL, urea 80 mg/dL with 
oligo anuria, and the patient was transferred to 
operating room (OR). 
The surgery consists in removing the old and 
new thrombus via catheters Fogarty on both femoral 
arteries. After the intervention the patient was 
admitted to the ICU 
At the time of admission to the ICU, blood 
sample analysis showed the following: creatinine 
1.76 mg/dL, urea 80 mg/dL, and potassium 5.4 mEq/L, 
and arterial blood gas analysis showed metabolic 
acidosis: pH 7.29, −7.6 base excess, serum 
bicarbonate 16mEq/L, partial pressure of oxygen 
79 mmHg and partial pressure of carbon dioxide 28.9 
mmHg of creatine phosphokinase (CK) 8500 U/L, with 
oliguria. The first hour after surgery the general 
condition of the patient is worsening with severe 
polipnea and hypoxia. In the gas analysis is found 
severe metabolic acidosis pH 7.12, pCO2 16.5 serum 
bicarbonate 13.5 BE -10. K- 8.2 meq. Because of the 
mentioned conditions the patient was intubated and 
placed on respiratory machine with assist controlled. 
The patient was hemodynamically unstable, and thus 
she was invasively monitored, requiring inotropic 
support with norepinephrine and infusion of crystalloid 
solutions in large amounts up to 8 liters in the first day 
because of the continuously low central venous 
pressure. After the cannulation of the left subclavian 
vein, is inserted a central catheter 2 lumen 12 Fr 
Arrow and Continuous veno-venous hemodiafiltration 
(CVVHDF) with Hospal AN69 Multiflow-150 hemofilter 
,Gambro was started with the sequent parameters: 
180 mL/min blood flow, predilution flow of 1000 mL, 
postdilution of 1000 mL, removal of 100 mL/hour, 
prefilter pressure of 180 mmHg and effluent pressure 
of 70 mmHg, with prefilter/effluent relationship 30/70. 
It is also started an aggressive correction of the 
metabolic acidosis and hyperkalemia with Ca glukonat 
and glucose sol + insuline.15 minutes after starting of 
the hemofiltration in the next gas analysis is notes 
severe acidosis with a K level up to 10 meq.  
Due to the fear of a cardiac arrest the 
parameters of the hemofilter were doubled up to 6 
liters per hour fluid exchange. Two hours after the 
initiation of this therapy the hemodynamic situation 
improves and the next gas analysis reveals an 
improved metabolic condition with ph 7,29 pcO2 18.6 
serum bicarbonate 18,6 BE -6  and K 7,5. We were 
strict to those regimens for the next hours until the K 
levels goes down to 5,5 meq, the set filter was 
changed every 12 hours. Six hours after the 
intervention it is done the fasciotomy of both legs due 
to the compartment syndrome. In the second day is 
done the TEE ultrasound and it is found a large 
thrombus in the left auricle partially in the roof of the 
atrium, for this reason the treatment with 
anticoagulants was more aggressive. The patient was 
kept in hemofiltration for approximately six days and 
gradually the patient’s diuresis started. On the 
seventh day the patient was extubated and the on the 
8
th
 day she was discharged to ward for further 
treatment of the legs. 
 
Discussion 
The acute renal failure, accompanied by 
myoglobinuria and hyperkalemia is a serious 
complication of the rhabdomyolisis due to prolonged 
ischemia and can be a life threatening condition. 
The myoglobin is a protein with a molecular 
mass up to 17.8 k Da that can be easily filtrated by the 
glomeruli and enters the tubular cells via endocitosis 
where is metabolized. It can be measured in the urine 
only when the values are above the renal threshold of 
1,5 mg /dl, and appears the tea discoloration of the 
urine when the level of the myoglobine is up to 100 
mg per deciliter. Although the exact mechanism of the 
glomerular damage through the rhabdomyolisis is still 
unknown, there are some supposed mechanisms [3] 
intrarenal vasoconstriction, [4] direct and ischemic 
tubular injury, and tubular obstruction. The 
myoglobine is concentrated along the renal tubules, a 
process that is emphasized from hypovolemia and 
renal vasoconstriction. Myoglobin seems to have no 
marked nephrotoxic effect on the tubules unless the 
urine is acidic. Myoglobine is heme protein that 
contains iron ions like ferrous oxide, which is 
necessary to maintain the oxygen molecule. However, 
molecular oxygen can promote the oxidation of 
ferrous to ferric oxide, thus generating a hydroxyl 
radical. This oxidative potential is neutralized from 
intracellular antioxidant molecules. However, cellular 
release of myoglobin leads to uncontrolled leakage of 
reactive oxygen species, and free radicals cause 
cellular injury [5]. 
The patients with rhabdomyolisis and renal 
failure, usually presents with volume depletion from 
the water sequestration in the damaged muscles. It is 
of main importance the aggressive correction of the 
fluid loss that can go up to 10 liters per day depending 
on the severity of the rhabdomyolisis. Clinical benefits 
of alkalinization as compared with simple volume 
repletion are not firmly established [6]. 
Some authors recommend the use of the 
renal replacement therapy in rhabdomyolisis only if 
there is progressive raise in kalium levels, oliguria 
(<0.5 mL of urine per kilogram per hour for 12 hours), 
anuria, volume overload, or resistant metabolic 
acidosis—pH < 7.1 [7]. Common techniques of 
dialysis have shown a limited capacity for removal of 
circulating myoglobin. In a recent article, some 
authors have proposed the use of a membrane of 
super-high-flow continuous hemofiltration with 
promising results [8]. 
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The myoglobine is a molecule with a weight of 
17.8 kDa, with electric charge and with a spherical 
shape, it is considered to be large to penetrate the 
pores through diffusion, so convection is required for it 
to be eliminated. Siewing coeficient of the myoglobine 
in the filter membranes CRRT is 0,6 and starts to 
decrease with the continuing use of the filter [9]. 
The solution proposed in recent studies by 
colleagues seems to be feasible and effective in 
removing myoglobin. The use of a continuous 
technique with a high-flux membrane hyperpermeable 
to myoglobin seems to guarantee the elimination of it. 
One possible limitation is represented by albumin 
leakage, which should be rigorously tested and 
evaluated [10]. 
In our case the patient came outside the time 
limit for the intervention of thrombectomy, but with the 
agreement of the patient and the relatives the surgeon 
decided for the intervention despite the risks due to 
the hyperkalemia form the rhabdomyolisis. We 
immediately decided to start the hemofiltration 
(CVVHDF) with Hospal AN69 Multiflow-100 
hemofilter, first with normal volumes and after due to 
the hyper kalemia we tripled the initial volumes. The 
mean sieving coefficient for myoglobin was 0.6 during 
the first 9 h of therapy and this decreased to 0.4 
during the following 7 h. For this reason the filter was 
changed every 12 hours to make possible the best 
performance in removing the myoglobin. Mean 
clearance of myoglobin was 22 ml/min, decreasing to 
14 ml/min during corresponding periods, while the 
mean ultrafiltration rates were relatively stable at 
2,353 +/- 140 ml/h and 2,274 +/- 82 ml/h, respectively. 
In contrast to myoglobin, the sieving coefficeint for 
urea, creatinine, and phosphorus remained stable at 
1.0 during the first 16 h of CVVH.  
In conclusion, despite the literature 
suggestions for the use of hyperpermeable 
membranes in CVVHD for the treatment of the acute 
renal failure from due to rhabdomiolysis, the use of 
high volume hemofiltration is an alternative in cases of 
life threatening complications (hyperkalemia). 
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